UNH Stock Surges 9% on Q1 2026 Beat: Is UnitedHealth's Turnaround Real?

# UNH Stock Surges 9% on Q1 2026 Beat: Is UnitedHealth's Turnaround Real?

> **Quick answer:** UnitedHealth Group beat Q1 2026 earnings estimates by a wide margin — $7.23 adjusted EPS versus the $6.58 consensus — and raised full-year guidance to more than $18.25 per share. The medical benefit ratio improved to 83.9%, its best Q1 reading in two years. UNH stock jumped 9.3% on the news, though shares remain roughly 22% below their 52-week high. The data is genuinely encouraging, but several structural risks — an active DOJ investigation and Medicare Advantage reimbursement headwinds — mean the turnaround is still being proven, not declared.

UnitedHealth Q1 2026 results delivered a jolt that Wall Street had not fully anticipated: a clean, broad-based earnings beat, an upward guidance revision, and — critically — a medical cost ratio that moved in the right direction for the first time in several quarters. The company's stock surged 9.3% on April 21, 2026, pulling the broader health insurance sector up with it, including a 5% sympathy rally in Humana shares.

*This article is for informational purposes only and does not constitute financial advice. Consult a qualified financial advisor for personal financial decisions.*

## The Numbers: What UNH Reported in Q1 2026

UnitedHealth Group's Q1 2026 results exceeded expectations across every major metric that analysts had flagged as critical heading into the print.